144: Filer Information

Filer CIK

0001658918

Filer CCC

XXXXXXXX

Is this a LIVE or TEST Filing?

LIVE

TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

MapLight Therapeutics, Inc.

SEC File Number

001-42914

Address of Issuer

800 CHESAPEAKE DRIVE
REDWOOD CITY
CALIFORNIA
94063

Phone

650-839-4360

Name of Person for Whose Account the Securities are To Be Sold

Kroeger Christopher A.

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Officer

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Common

Jefferies LLC
520 Madison Avenue
4th Floor
New York � NY � 10022

152230

5771039.30

42620000

07/15/2026

NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Common

05/02/2024

Restricted Stock Unit Grant

Maplight Therapeutics, Inc.

24223

05/02/2024

N/A

Common

11/09/2023

Restricted Stock Unit Grant

Maplight Therapeutics, Inc.

7664

11/09/2023

N/A

Common

07/30/2023

Restricted Stock Unit Grant

Maplight Therapeutics, Inc.

14845

07/30/2023

N/A

Common

07/18/2025

Restricted Stock Unit Grant

Maplight Therapeutics, Inc.

248925

07/18/2025

N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds

Christopher Kroeger
800 Chesapeake Drive
Redwood City � CA � 94063

Common

05/18/2026

118235

3215511.97

Christopher Kroeger
800 Chesapeake Drive
Redwood City � CA � 94063

Common

05/11/2026

13980

420966.60

Christopher Kroeger
800 Chesapeake Drive
Redwood City � CA � 94063

Common

05/08/2026

34411

952905.28

Christopher Kroeger
800 Chesapeake Drive
Redwood City � CA � 94063

Common

05/07/2026

20100

575774.55

Christopher Kroeger
800 Chesapeake Drive
Redwood City � CA � 94063

Common

05/06/2026

23701

681645.26

Christopher Kroeger
800 Chesapeake Drive
Redwood City � CA � 94063

Common

05/05/2026

10742

295283.80

Christopher Kroeger
800 Chesapeake Drive
Redwood City � CA � 94603

Common

05/04/2026

15571

435312.69

Christopher Kroeger
800 Chesapeake Drive
Redwood City � CA � 94603

Common

04/17/2026

10052

275140.33

Christopher Kroeger
800 Chesapeake Drive
Redwood City � CA � 94063

Common

04/16/2026

10053

275167.70

Christopher Kroeger
800 Chesapeake Drive
Redwood City � CA � 94063

Common

04/15/2026

9135

246020.99

144: Remarks and Signature

Remarks

Shares to be sold solely to satisfy tax-withholding obligations in connection w/RSU vesting

Date of Notice

07/15/2026

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Christopher Kroeger

144: Filer Information

Submission Contact Information

144: Issuer Information

144: Securities Information

144: Securities To Be Sold

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

ATTENTION:

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)